search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Monitoring & metering


Keeping tabs on vaccines in the battle against coviD-19


ensure that they are in the required condition before being administered to patients in the battle against COVID-19? Hanwell Solutions says its ShockWatch


H


monitoring solutions are ideal for the storage temperature of COVID-19 vaccines, which must be maintained at the correct temperature during both transport and when they reach their destination. Coronavirus jabs being produced by


Oxford University/AstraZeneca (which requires temperature monitoring of between -2 to +8°C), Moderna and the Valneva candidate, which is undergoing clinical trials in Scotland, do not require a super cold environment, but still need to be stored in medical freezers or fridges or else the vaccine is rendered ineffective. Multi-award-winning Hanwell recommends the use of Shockwatch’s WarmMark monitoring


ow do you monitor millions of doses of vaccines that are being rolled out across the world to


system, a single-use, ascending time- temperature indicator which alerts users of exposure to unacceptable temperature conditions through a coloured window system on a single card tab. The leading manufacturer of wireless environmental monitoring equipment says WarmMark is a better option than data loggers because it is a cost-effective solution that continues to look after vaccines over a sustained period of time, verifying at the point of use that temperatures have or have not been breached. Data loggers have to be manually read


or downloaded for analysis, but that is an after-the-fact discovery of temperature excursions. WarmMark allows quick and easy-to-view real-time monitoring and reporting of conditions gone astray, enabling quick response and correction – preventing loss of product and ultimately protecting patients from being administered a vaccine that has breached the integrity of the cold chain. In addition to WarmMark, Hanwell also


supplies its renowned IceSpy system for providing cost-effective solutions for wireless temperature monitoring within fridges and freezers, while its robust iSense product is an innovative self- contained unit enabling remote environmental monitoring of buildings, machinery, infrastructure or vehicles. Derek Richardson, Hanwell’s International


sales director, says the WarmMark solution is another safeguard for maintaining the effectiveness of vaccines during transport and when in cold storage facilities, needed during these critical times. He explains: “Transport could be a weak


link in terms of safety procedures due to inconsistent environmental conditions, but the WarmMark system will clearly show up red if vaccines – or indeed any other pharmaceutical products – have been compromised by a temperature breach. This could be a Godsend for the UK’s inoculation program which is likely to make use of completely new and untried non- medical facilities to store and administer the vaccines. “Recent reports have shown that


£5.8million worth of vaccines were wasted in 2019, mostly through breaching correct storage temperatures. Having WarmMark monitoring in place should encourage all those who are responsible for the safety of these precious jabs to do their utmost to safeguard them under proper conditions.”


Hanwell Solutions 28 www.hanwell.com April 2021 Instrumentation Monthly


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74